All our latest news

By Stefan Cross, Senior Scientist This May, Crux Biolabs is proud to be part of an important conversation—one that may shape the trajectory of early-phase clinical development for biotech and small pharma companies in Switzerland and beyond. And we are…

By Ester Lopez, Senior Scientist Understanding the potential of a biotherapeutic to trigger an unwanted immune response is a fundamental part of the drug development process. This response, known as immunogenicity, results in the production of anti-drug antibodies (ADAs) which…

By Paul Della Gatta, PhD, Head of Business Development Biomarkers are at the forefront of modern drug development, playing an essential role in monitoring disease status and assessing the efficacy of drug products in clinical trials. Crux Biolabs specialises in…

By Eze Nwoke, PhD, Technical Lead, Flow Cytometry Biologics offer the potential for substantial improvements in patient outcomes, particularly in conditions such as cancer and autoimmune disorders. While typically inducing only a minor, transient immune response, biologics can occasionally trigger…

By Livleen Kaur, PhD, Senior Scientist At Crux Biolabs, we specialise in custom biomarker assay services designed to meet the unique needs of our clients in drug development and clinical research. Whether you're in the early stages of research or…

By Tara Alvarez, PhD, Senior Scientist Flow cytometry is a powerful tool in drug development and clinical research, enabling precise analysis of individual cells to accelerate the discovery and validation of new treatments. Recognising that most studies come with unique…

by Anita Yusim As you undertake bioanalytical testing, having reliable and validated assays is essential to ensuring that your data is accurate, reproducible, and regulatory-compliant. That's why Crux Biolabs offers a range of off-the-shelf, pre-verified/pre-validated assays that can significantly streamline…

AusBiotech'24 is the preeminent national conference for the Australian pharma and biotech sector.  Once a year, it serves as an opportunity to bring the industry together, celebrate what has been achieved, and showcase all the things that are possible in…

Flow cytometry is often a critical part of clinical research. It is used to assess multiple parameters, including pharmacodynamics and pharmacokinetics via receptor occupancy assays.  It can also be used for efficiency testing within vaccine studies.  The main advantage of…

KCAS Bio has selected Crux Biolabs (Melbourne, Australia) as its partner in providing harmonised spectral flow cytometry across the US, Europe, and Australia.  The alliance enables KCAS Bio and Crux Biolabs to support the global needs of clinical research by…